Výsledky vyhledávání - "Imad Adbi Haloob"

Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial

Autor: Joanna L. Dunlop, Alain C. Vandal, Ruvin Gabriel, Kannaiyan Samuel Rabindranath, John B. W. Schollum, David O. McGregor, Janak de Zoysa, Philip James Matheson, Mark R. Marshall, David Semple, Tian Min Ma, John Irvine, Imad Adbi Haloob, Rose Sisk, Zhengxiu Xie, Christopher John Hood

Publikováno v: J Am Soc Nephrol

Background Fluid overload in patients undergoing hemodialysis contributes to cardiovascular morbidity and mortality. There is a global trend to lower dialysate sodium with the goal of reducing fluid overload. Methods To investigate whether lower dial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b990023268f9d2a6510e27d149e034cc
https://doi.org/10.1681/asn.2019090877

Zobrazit plný text záznamu

Metformin associated lactic acidosis in Auckland City Hospital 2005 to 2009

Autor: Janak de Zoysa, Imad Adbi Haloob

Publikováno v: World journal of nephrology. 5(4)

AIM: To determine the incidence, clinical characteristics and outcomes of patients with metformin associated lactic acidosis (MALA). METHODS: Auckland City Hospital drains a population of just over 400000 people. All cases presenting with metabolic a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a9a87f17608572a0ec14d149fa589d9
https://pubmed.ncbi.nlm.nih.gov/27458565

Zobrazit plný text záznamu

Effect of Antimicrobial Locks for Tunneled Hemodialysis Catheters on Bloodstream Infection and Bacterial Resistance: A Quality Improvement Report

Autor: Elizabeth M. Curry, Mark R. Marshall, Saib A. Abbas, Bruce B. King, Walter M. Van der Merwe, Imad Adbi Haloob, Susan Taylor

Publikováno v: American Journal of Kidney Diseases. 53:492-502

Background Catheter-restricted antimicrobial lock (AML) use reduces catheter-associated bloodstream infection (CA-BSI) in clinical trial settings, but may not be as effective in clinical settings and may increase bacterial resistance. Design Quality

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc2e4541f10cd24b3c616e194d755962
https://doi.org/10.1053/j.ajkd.2008.09.019

Zobrazit plný text záznamu

Associations of a facility level decrease in dialysate sodium concentration with blood pressure and interdialytic weight gain

Autor: Hla Thein, Imad Adbi Haloob, Mark R. Marshall

Publikováno v: Nephrology Dialysis Transplantation. 22:2630-2639

Background. Dialysate [Na þ ] is often overlooked as a contributor to hypertension in patients on haemodialysis (HD). We report observational experience with a facility level decrease in dialysate [Na þ ] from 141 mmol/l to 138 mmol/l, in the absen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::126849420f23e20f75c4f56d01c7b719
https://doi.org/10.1093/ndt/gfm220

Zobrazit plný text záznamu

Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass

Autor: Alain C. Vandal, Joanna L. Dunlop, Christopher John Hood, Ruvin Gabriel, David Semple, Kannaiyan Samuel Rabindranath, Philip James Matheson, Janak de Zoysa, David O. McGregor, Imad Adbi Haloob, Mark R. Marshall

Publikováno v: BMC Nephrology

After the publication of our paper Dunlop et al. “Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24000709b727c6ee9da702c0272104eb
https://pubmed.ncbi.nlm.nih.gov/26248851

Zobrazit plný text záznamu

Rationale and design of the myocardial microinjury and cardiac remodeling extension study in the sodium lowering in dialysate trial (Mac-SoLID study)

Autor: Ruvin Gabriel, Kannaiyan Samuel Rabindranath, Imad Adbi Haloob, David O. McGregor, Lukas Mathias Gerber, Alain C. Vandal, John Irvine, Joanna L. Dunlop, Janak de Zoysa, John Benedict William Schollum, Philip James Matheson, Mark R. Marshall, David Semple, Christopher John Hood

Publikováno v: BMC Nephrology

Background The Sodium Lowering in Dialysate (SoLID) trial is an ongoing a multi-center, prospective, randomised, single-blind (assessor), controlled, parallel assignment clinical trial, enrolling 96 home and self-care hemodialysis (HD) patients from

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb065a585b931b118428eaaf8b1d9ad9
https://doi.org/10.1186/1471-2369-15-120

Zobrazit plný text záznamu

Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass

Autor: David O. McGregor, Mark R. Marshall, Joanna L. Dunlop, David Semple, Imad Adbi Haloob, Philip James Matheson, Janak de Zoysa, Alain C. Vandal, Ruvin Gabriel, Kannaiyan Samuel Rabindranath, Christopher John Hood

Publikováno v: BMC Nephrology

Background The current literature recognises that left ventricular hypertrophy makes a key contribution to the high rate of premature cardiovascular mortality in dialysis patients. Determining how we might intervene to ameliorate left ventricular hyp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c66a354246162ed44fdb2bfd81900bca
https://pubmed.ncbi.nlm.nih.gov/23855560

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání